TY  - BOOK
AU  - Jonklaas, Jacqueline
TI  - Update on the treatment of hypothyroidism. [Review]
SN  - 1040-8746
PY  - 2016///
KW  - *Hypothyroidism/dt [Drug Therapy]
KW  - *Thyroid Neoplasms/su [Surgery]
KW  - *Thyroidectomy/ae [Adverse Effects]
KW  - *Thyrotropin/bl [Blood]
KW  - Age Factors
KW  - Animals
KW  - Body Weight
KW  - Humans
KW  - Hypothyroidism/et [Etiology]
KW  - Quality of Life
KW  - Thyroidectomy/mt [Methods]
KW  - Thyroxine/ad [Administration & Dosage]
KW  - Thyroxine/tu [Therapeutic Use]
KW  - MedStar Washington Hospital Center
KW  - Medicine/Endocrinology
KW  - Journal Article
KW  - Research Support, N.I.H., Extramural
KW  - Review
N1  - Available online from MWHC library: 1999 - present
N2  - PURPOSE OF REVIEW: Differentiated thyroid cancer is a malignancy that is rapidly increasing in frequency. As thyroidectomy plays a central role in the treatment of thyroid cancer, it is incumbent on physicians treating this patient group to be well versed in the intricacies of treating hypothyroidism; RECENT FINDINGS: Treatment of hypothyroidism may be refined by careful attention to dose selection, monitoring of therapy and achievement of thyrotropin goals that are specific to the individual patient's overall clinical situation. These goals are common not only to patients with a sole diagnosis of hypothyroidism, as discussed in the recent American Thyroid Association Guidelines, but also to patients with hypothyroidism in the setting of thyroid cancer. Several recent studies have illuminated our understanding of the benefits and risks of thyrotropin suppression therapy in patients with differentiated thyroid cancer. Multiple studies of combination therapy with levothyroxine and liothyronine for treating hypothyroidism have not led to a clear conclusion about its benefits over levothyroxine monotherapy. Animal studies have advanced our understanding of the altered serum and tissue milieu that characterizes levothyroxine monotherapy. Crossing the bridge from this translational research into clinical research using sustained release triiodothyronine preparations may ultimately enhance the health of our patients; SUMMARY: Continued refinement of our understanding of thyroid status and our ability to flawlessly implement thyroid hormone replacement is an active area of research
UR  - http://dx.doi.org/10.1097/CCO.0000000000000242
ER  -